Interleukin-6 Inhibition with Tocilizumab for Relapsing MOG-IgG Associated Disorder

被引：0
|
作者：
Elsbernd, Paul [1 ]
Hoffmann, William [2 ]
Wingerchuk, Dean [3 ]
Carter, Jonathan [3 ]
机构：
[1] Mayo Clin, Neurol, Tempe, AZ USA
[2] Brooke Army Med Ctr, Neurol, Tempe, AZ USA
[3] Mayo Clin, Tempe, AZ USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
11
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases
    Komaba, Hirotaka
    Nakazawa, Takashi
    Yamaguchi, Yutaka
    Kumagai, Shunichi
    Fukagawa, Masafumi
    CLINICAL KIDNEY JOURNAL, 2008, 1 (06): : 423 - 426
  • [42] Longitudinal assessment of cognitive function in nonrelapsing MOG-IgG associated disease: a case series.
    Risi, Mario
    Altieri, Manuela
    Rippa, Valentina
    Borgo, Riccardo Maria
    Ambrosio, Alessandro D'
    Docimo, Renato
    Marotta, Chiara
    Bisecco, Alvino
    Gallo, Antonio
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 715 - 716
  • [43] Tocilizumab: An Interleukin-6 Receptor Inhibitor for the Treatment of Rheumatoid Arthritis
    Plushner, Susyn L.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (11) : 1660 - 1668
  • [44] Interleukin-6 Signaling With Tocilizumab Requires Sex Specific Dosing
    Hudobenko, Jacob
    Chauhan, Anjali
    McCullough, Louise
    STROKE, 2019, 50
  • [45] Role of Interleukin-6 in Depressive Disorder
    Ting, Emily Yi-Chih
    Yang, Albert C.
    Tsai, Shih-Jen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [46] Inhibition of interleukin-6 by tocilizumab improves endothelial glycocalyx and myocardial work index in patients with rheumatoid arthritis
    Ikonomidis, I.
    Pavlidis, G.
    Katsimbri, P.
    Thymis, J.
    Birba, D.
    Kostelli, G.
    Katogiannis, K.
    Makavos, G.
    Andreadou, I
    Frogoudaki, A.
    Vrettou, A. R.
    Boumpas, D.
    Iliodromitis, E.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3157 - 3157
  • [47] Clinical experience with inhibition of interleukin-6
    Choy, E
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (02) : 405 - +
  • [48] INTERLEUKIN-6 INHIBITION WITH TOCILIZUMAB FOR THE TREATMENT OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA IN PATIENTS WITH SERIOUS COMORBIDITIES
    Beketova, T.
    Otteva, E.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1524 - 1525
  • [49] Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumab
    Lee, Janet S.
    Chapman, M. John
    Piraino, Paolo
    Lamerz, Jens
    Schindler, Thomas
    Cutler, Paul
    Dernick, Gregor
    PROTEOMICS CLINICAL APPLICATIONS, 2016, 10 (02) : 183 - 194
  • [50] Inhibition of Interleukin-6 Signaling With Tocilizumab Ameliorates Ischemic Stroke Damage in Aged Male and Female Mice
    Hudobenko, Jacob
    Chauhan, Anjali
    McCullough, Louise
    STROKE, 2018, 49
12345